Skip to main content

Advertisement

Log in

Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?

  • Letter to the Editor
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Delvecchio M, Mozzillo E, Salzano G et al (2017) Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetes (ISPED). Monogenic diabetes accounts for 6.3% of cases referred to 15 Italian pediatric diabetes centers during 2007 to 2012. J Clin Endocrinol Metab 102:1826–1834

    Article  PubMed  Google Scholar 

  2. Shepherd M, Shields B, Hammersley S et al (2016) Systematic population screening, using biomarkers and genetic testing, identifies 2.5% of the U.K. pediatric diabetes population with monogenic diabetes. Diabetes Care 39:1879–1888

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Shields BM, Shepherd M, Hudson M et al (2017) Population-based assessment of a biomarker-based screening pathway to aid diagnosis of monogenic diabetes in young-onset patients. Diabetes Care 40:1017–1025

    Article  PubMed  PubMed Central  Google Scholar 

  4. Stride A, Vaxillaire M, Tuomi T et al (2002) The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia 45:427–435

    Article  PubMed  CAS  Google Scholar 

  5. Pinelli M, Acquaviva F, Barbetti F et al (2013) Identification of candidate children for Maturity Onset Daiabetes of the Young type 2 (MODY 2) genetic testing: a seven item clinical flow-chart. PLoS One 8:e79933

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Contributions

All Authors and contributors researched data and critically reviewed the paper. MD collected data, performed statistics and drafted the paper. AN performed statistics. FB, the guarantor of the paper, conceived the study, collected data, and critically revised the manuscript.

Corresponding authors

Correspondence to Maurizio Delvecchio or Fabrizio Barbetti.

Ethics declarations

Conflict of interest

Authors have no conflict of interest to declare.

Human and animal rights

All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committe and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Fot this type of study formal consent is not required.

Additional information

Managed by Massimo Porta.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Delvecchio, M., Salzano, G., Bonura, C. et al. Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?. Acta Diabetol 55, 981–983 (2018). https://doi.org/10.1007/s00592-018-1179-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-018-1179-y

Keywords

Navigation